Order Article Reprints

Dorraji E, Borgen E, Segura-Peña D, Rawat P, Smorodina E, Dunn C, Greiff V, Sekulić N, Russnes H, Kyte JA. Development of a High-Affinity Antibody against the Tumor-Specific and Hyperactive 611-p95HER2 Isoform. Cancers. 2022; 14(19):4859. https://doi.org/10.3390/cancers14194859

Dorraji, Esmaeil, Elin Borgen, Dario Segura-Peña, Puneet Rawat, Eva Smorodina, Claire Dunn, Victor Greiff, Nikolina Sekulić, Hege Russnes, and Jon Amund Kyte. 2022. "Development of a High-Affinity Antibody against the Tumor-Specific and Hyperactive 611-p95HER2 Isoform" Cancers 14, no. 19: 4859. https://doi.org/10.3390/cancers14194859

Dorraji, E., Borgen, E., Segura-Peña, D., Rawat, P., Smorodina, E., Dunn, C., Greiff, V., Sekulić, N., Russnes, H., & Kyte, J. A. (2022). Development of a High-Affinity Antibody against the Tumor-Specific and Hyperactive 611-p95HER2 Isoform. Cancers, 14(19), 4859. https://doi.org/10.3390/cancers14194859